• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未折叠蛋白反应在治疗抵抗中的新兴机制:从化疗到免疫治疗。

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.

机构信息

Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China.

Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, China.

出版信息

Cell Commun Signal. 2024 Jan 31;22(1):89. doi: 10.1186/s12964-023-01438-0.

DOI:10.1186/s12964-023-01438-0
PMID:38297380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10832166/
Abstract

The accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activates the unfolded protein response (UPR). As an adaptive cellular response to hostile microenvironments, such as hypoxia, nutrient deprivation, oxidative stress, and chemotherapeutic drugs, the UPR is activated in diverse cancer types and functions as a dynamic tumour promoter in cancer development; this role of the UPR indicates that regulation of the UPR can be utilized as a target for tumour treatment. T-cell exhaustion mainly refers to effector T cells losing their effector functions and expressing inhibitory receptors, leading to tumour immune evasion and the loss of tumour control. Emerging evidence suggests that the UPR plays a crucial role in T-cell exhaustion, immune evasion, and resistance to immunotherapy. In this review, we summarize the molecular basis of UPR activation, the effect of the UPR on immune evasion, the emerging mechanisms of the UPR in chemotherapy and immunotherapy resistance, and agents that target the UPR for tumour therapeutics. An understanding of the role of the UPR in immune evasion and therapeutic resistance will be helpful to identify new therapeutic modalities for cancer treatment. Video Abstract.

摘要

内质网(ER)中未折叠或错误折叠蛋白质的积累会导致 ER 应激,并激活未折叠蛋白反应(UPR)。作为一种对缺氧、营养缺乏、氧化应激和化疗药物等恶劣微环境的适应性细胞反应,UPR 在多种癌症类型中被激活,并在癌症发展中作为一个动态的肿瘤促进因子发挥作用;UPR 的这一作用表明,调节 UPR 可以作为肿瘤治疗的靶点。T 细胞耗竭主要是指效应 T 细胞失去效应功能并表达抑制性受体,导致肿瘤免疫逃逸和肿瘤控制的丧失。新出现的证据表明,UPR 在 T 细胞耗竭、免疫逃逸和对免疫治疗的抵抗中起着关键作用。在这篇综述中,我们总结了 UPR 激活的分子基础、UPR 对免疫逃逸的影响、UPR 在化疗和免疫治疗耐药性中的新机制,以及针对 UPR 的肿瘤治疗药物。了解 UPR 在免疫逃逸和治疗耐药性中的作用将有助于为癌症治疗确定新的治疗模式。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/99da55cd397f/12964_2023_1438_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/3ece89755f23/12964_2023_1438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/9109d3488686/12964_2023_1438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/5f35b05b76ea/12964_2023_1438_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/99da55cd397f/12964_2023_1438_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/3ece89755f23/12964_2023_1438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/9109d3488686/12964_2023_1438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/5f35b05b76ea/12964_2023_1438_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b54/10832166/99da55cd397f/12964_2023_1438_Fig4_HTML.jpg

相似文献

1
Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.未折叠蛋白反应在治疗抵抗中的新兴机制:从化疗到免疫治疗。
Cell Commun Signal. 2024 Jan 31;22(1):89. doi: 10.1186/s12964-023-01438-0.
2
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy.内质网应激调节肿瘤生长和抗肿瘤免疫:癌症免疫治疗的一个有前景的机会。
Cancer Immunol Immunother. 2017 Aug;66(8):1069-1078. doi: 10.1007/s00262-017-2019-6. Epub 2017 Jun 2.
3
Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy.靶向 UPR 分支,提高癌症化疗疗效的潜在策略。
Acta Biochim Biophys Sin (Shanghai). 2021 Nov 10;53(11):1417-1427. doi: 10.1093/abbs/gmab131.
4
Endoplasmic Reticulum Stress and Cancer: Could Unfolded Protein Response Be a Druggable Target for Cancer Therapy?内质网应激与癌症:未折叠蛋白反应能否成为癌症治疗的可靶向目标?
Int J Mol Sci. 2023 Jan 13;24(2):1566. doi: 10.3390/ijms24021566.
5
An Overview of Unfolded Protein Response Signaling and Its Role in Cancer. unfolded 蛋白反应信号及其在癌症中的作用概述。
Cancer Biother Radiopharm. 2017 Oct;32(8):275-281. doi: 10.1089/cbr.2017.2309.
6
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.PERK诱导细胞对内质网应激和化疗引发的细胞死亡产生抗性。
Mol Cancer. 2017 May 12;16(1):91. doi: 10.1186/s12943-017-0657-0.
7
Endoplasmic reticulum proteostasis: a key checkpoint in cancer.内质网蛋白质稳态:癌症中的关键检查点。
Am J Physiol Cell Physiol. 2017 Feb 1;312(2):C93-C102. doi: 10.1152/ajpcell.00266.2016. Epub 2016 Nov 16.
8
The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma.内质网应激/未折叠蛋白反应在胶质瘤发生、肿瘤进展中的作用及作为胶质母细胞瘤的治疗靶点
Biochem Pharmacol. 2016 Oct 15;118:1-8. doi: 10.1016/j.bcp.2016.04.008. Epub 2016 Apr 19.
9
The impact of the endoplasmic reticulum protein-folding environment on cancer development.内质网蛋白折叠环境对癌症发展的影响。
Nat Rev Cancer. 2014 Sep;14(9):581-97. doi: 10.1038/nrc3800.
10
Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia.了解内质网稳态和未折叠蛋白反应以提高急性髓系白血病的治疗效果。
Drug Resist Updat. 2022 Sep;64:100853. doi: 10.1016/j.drup.2022.100853. Epub 2022 Jul 8.

引用本文的文献

1
The protein kinases family in fungi: adaptability, virulence and conservation between species.真菌中的蛋白激酶家族:物种间的适应性、毒力与保守性
Front Microbiol. 2025 Aug 15;16:1630196. doi: 10.3389/fmicb.2025.1630196. eCollection 2025.
2
Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids.2型糖尿病患者的血浆外泌体在患者来源的类器官中促进乳腺癌侵袭。
Commun Biol. 2025 Aug 26;8(1):1276. doi: 10.1038/s42003-025-08663-y.
3
Integrated Nanopore and short-read RNA sequencing identifies dysregulation of METTL3- m6A modifications in endocrine therapy- sensitive and resistant breast cancer cells.

本文引用的文献

1
Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17/CXCL22-CCR4-ATF6-GRP78 axis.肿瘤相关巨噬细胞通过细胞间 CXCL17/CXCL22-CCR4-ATF6-GRP78 轴促进 MRP1 膜易位赋予结直肠癌细胞 5-氟尿嘧啶耐药性。
Cell Death Dis. 2023 Sep 1;14(9):582. doi: 10.1038/s41419-023-06108-0.
2
The expression profiles of signature genes from CD103LAG3 tumour-infiltrating lymphocyte subsets predict breast cancer survival.CD103+LAG3−和 CD103−LAG3+肿瘤浸润淋巴细胞亚群的特征基因表达谱可预测乳腺癌患者的生存情况。
BMC Med. 2023 Jul 24;21(1):268. doi: 10.1186/s12916-023-02960-1.
3
整合纳米孔和短读长RNA测序鉴定内分泌治疗敏感和耐药乳腺癌细胞中METTL3-m6A修饰的失调
Funct Integr Genomics. 2025 Jul 9;25(1):149. doi: 10.1007/s10142-025-01658-2.
4
Endoplasmic reticulum stress responses in anticancer immunity.内质网应激反应在抗癌免疫中的作用
Nat Rev Cancer. 2025 Jun 24. doi: 10.1038/s41568-025-00836-5.
5
Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress.补充唾液酸类似物通过加剧内质网应激克服三阴性乳腺癌的放疗抗性。
Redox Biol. 2025 Jun 7;85:103712. doi: 10.1016/j.redox.2025.103712.
6
Redox regulation of lung endothelial PERK, unfolded protein response (UPR) and proliferation via NOX1: Targeted inhibition as a potential therapy for PAH.通过NOX1对肺内皮细胞PERK、未折叠蛋白反应(UPR)和增殖的氧化还原调节:靶向抑制作为肺动脉高压的潜在治疗方法。
Redox Biol. 2025 May;82:103554. doi: 10.1016/j.redox.2025.103554. Epub 2025 Feb 19.
7
Predictive and Prognostic Values of Glycoprotein 96, Androgen Receptors, and Extranodal Extension in Sentinel Lymph Node-Positive Breast Cancer: An Immunohistochemical Retrospective Study.糖蛋白96、雄激素受体及前哨淋巴结阳性乳腺癌结外侵犯的预测和预后价值:一项免疫组织化学回顾性研究
J Clin Med. 2024 Dec 16;13(24):7665. doi: 10.3390/jcm13247665.
8
Innovative label-free lymphoma diagnosis using infrared spectroscopy and machine learning on tissue sections.利用组织切片的红外光谱和机器学习进行创新的无标记淋巴瘤诊断。
Commun Biol. 2024 Oct 31;7(1):1419. doi: 10.1038/s42003-024-07111-7.
9
Endothelial Unfolded Protein Response-Mediated Cytoskeletal Effects.内皮细胞未折叠蛋白反应介导的细胞骨架效应。
Cell Biochem Funct. 2024 Dec;42(8):e70007. doi: 10.1002/cbf.70007.
10
Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy.可溶性间皮素相关肽作为接受检查点免疫治疗的胸膜间皮瘤患者的预后指标。
J Thorac Cardiovasc Surg. 2025 Apr;169(4):1082-1095.e4. doi: 10.1016/j.jtcvs.2024.10.005. Epub 2024 Oct 10.
Endoplasmic reticulum stress targeted therapy for breast cancer.
内质网应激靶向治疗乳腺癌。
Cell Commun Signal. 2022 Nov 7;20(1):174. doi: 10.1186/s12964-022-00964-7.
4
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review.早期非小细胞肺癌与晚期非小细胞肺癌免疫治疗疗效比较:系统评价。
BMC Med. 2022 Nov 7;20(1):426. doi: 10.1186/s12916-022-02580-1.
5
Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy.多功能纳米载药系统中联合自噬抑制剂、免疫佐剂和抗 PD-L1 抗体用于增强乳腺癌免疫治疗。
BMC Med. 2022 Oct 28;20(1):411. doi: 10.1186/s12916-022-02614-8.
6
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.ATF6 介导的信号通路参与卵巢癌对 PARP 抑制剂的耐药。
Mol Cancer Res. 2023 Jan 3;21(1):3-13. doi: 10.1158/1541-7786.MCR-22-0102.
7
New insights into IRE1α activation and function in anti-tumor immunity.IRE1α 在抗肿瘤免疫中的激活和功能的新见解。
J Cell Biol. 2022 Jun 6;221(6). doi: 10.1083/jcb.202205019. Epub 2022 May 11.
8
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche.静止期癌细胞通过形成免疫抑制微环境来抵抗 T 细胞攻击。
Cell. 2022 May 12;185(10):1694-1708.e19. doi: 10.1016/j.cell.2022.03.033. Epub 2022 Apr 20.
9
Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation.抗原衍生肽通过与内质网应激传感器 IRE1α 结合来抑制树突状细胞的交叉呈递。
J Cell Biol. 2022 Jun 6;221(6). doi: 10.1083/jcb.202111068. Epub 2022 Apr 21.
10
Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma.PI3K-AKT-mTOR 通路突变作为预测错配修复缺陷/微卫星高度不稳定型胃腺癌免疫细胞浸润和免疫治疗疗效的标志物。
BMC Med. 2022 Apr 21;20(1):133. doi: 10.1186/s12916-022-02327-y.